Wednesday, April 05, 2017 8:17:52 PM
Safety and Product Labeling Advantage for KIT-302 The FDA now requires a ‘black box’ warning on NSAIDs stating that although the drug offers pain relief, it carries risks of heart attack, stroke, and death. Kitov anticipates that KIT-302 would carry a label indicating it reduces blood pressure, risk of heart attack, stroke, and death. Using one pill instead of two increases patient safety and patient compliance, while reducing doctor liability and drug costs.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM